背景:胸廓出口综合征(TOS)通常被认为是成年人的一种疾病;由于其在儿科中的认识有限,因此在儿童和青少年中通常被忽略。本研究旨在系统地回顾和提供对儿科患者TOS的见解。
方法:PubMed,Scopus,WebofScience,和谷歌学者数据库被彻底搜索英语语言研究发表到3月15日,2024.该研究包括那些专注于诊断为TOS的儿科或青少年个体的文章。从包含发表日期的研究中收集的数据,参与者或报告病例的数量,年龄(岁),参与者的性别,TOS类型,患侧,治疗类型,手术方法,骨异常,症状持续时间(月),结果,和随访时间(月)。
结果:当前的研究包括33篇文章,其中21例是病例报告,其中10个是案例系列,其余为队列研究.在这项研究中,356名患者被纳入。女性占患者人口的234(65.73%)。在TOS类型中,神经源性TOS共201例(56.5%).193名(54%)患者存在与运动相关的活动或身体活动,其次是27(7%)患者的外伤史。
结论:儿科患者的血管TOS百分比高于成人患者,随着锁骨上入路成为首选的治疗方法。与运动相关的活动被确定为与小儿TOS相关的主要危险因素。
BACKGROUND: Thoracic outlet syndrome (TOS) typically considered a condition of the adult population; it is often disregarded in children and adolescents due to its limited recognition within the pediatrics. The current study aims to systematically review and provide insights into TOS among pediatric patients.
METHODS: PubMed, Scopus, Web of Science, and Google Scholar databases were thoroughly searched for English language studies published until March 15th, 2024. The study included those articles focusing on pediatric or adolescent individuals diagnosed with TOS. Data collected from studies encompassed date of publication, number of participants or reported cases, age (years), gender of participants, type of TOS, affected side, type of treatment, surgical approach, bony abnormality, duration of symptoms (months), outcome, and follow-up time duration (months).
RESULTS: The current study comprised 33 articles, 21 of which were case reports, 10 of which were case series, and the remaining were cohort studies. In this study, 356 patients were included. Females constituted 234 (65.73%) of the patient population. Among TOS types, neurogenic TOS was found among 201 (56.5%) patients. Sporting-related activity or physical activity was present in 193 (54%) patients, followed by a history of trauma in 27 (7%) patients.
CONCLUSIONS: Pediatric patients exhibited a higher percentage of vascular TOS than their adult counterparts, with the supraclavicular approach emerging as the preferred treatment method. Sports-related activities were identified as the primary risk factor associated with pediatric TOS.